Anebulo Pharmaceuticals

-$0.15 (-2.08%) As of 2:26 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANEB and other ETFs, options, and stocks.

About ANEB

Anebulo Pharmaceuticals, Inc. engages in the provision of pharmaceutical services. The firm product candidate is ANEB-001, a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose.

CEO
Daniel Schneeberger
Employees
3
Headquarters
Lakeway, Texas
Founded
2020

ANEB Key Statistics

Market Cap
164.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.25K
High Today
$7.24
Low Today
$7.05
Open Price
$7.24
Volume
324.00
52 Week High
$9.33
52 Week Low
$6.31

ANEB Earnings

-$0.69
-$0.46
-$0.23
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Jan 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure